Correction: Deep Sequencing of T-Cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer After Immunotherapy

Cancer immunology research - United States
doi 10.1158/2326-6066.cir-17-0048
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

miR-17 as a Diagnostic Biomarker Regulates Cell Proliferation in Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2017English

Cell-Free DNA as a Biomarker of Aging

Aging Cell
AgingCell Biology
2018English

T Cell Landscape Within Primary Melanoma as a Biomarker of Survival After Cancer Vaccination in Patients With Metastatic Disease

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Development of a T-Cell Receptor Mimic Antibody Against Wild-Type P53 for Cancer Immunotherapy

Cancer Research
Cancer ResearchOncology
2017English

Characterization of Human Prostate and Breast Cancer Cell Lines for Experimental T Cell-Based Immunotherapy

Prostate
OncologyUrology
2007English

Chimeric NKG2D Receptor-Bearing T Cells as Immunotherapy for Ovarian Cancer

Cancer Research
Cancer ResearchOncology
2007English

IL15 and T-Cell Stemness in T-Cell-Based Cancer Immunotherapy

Cancer Research
Cancer ResearchOncology
2015English

DNA Repair Capacity as a Possible Biomarker of Breast Cancer Risk in Female BRCA1 Mutation Carriers

British Journal of Cancer
Cancer ResearchOncology
2007English

Total Costs of Chimeric Antigen Receptor T-Cell Immunotherapy

JAMA Oncology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy